|
| Exchange Disseminated Time | In compliance with the requirements of the SEBI (Prohibition of Insider Trading) Regulations, 2015 ("the Regulations") the Pfizer Ltd has informed BSE as follows;
1. Pursuant to the requirements of Regulation 8(2) of the Regulations, the Company has formulated the "Code of Practices and Procedures for Fair Disclosure of Unpublished Price Sensitive Information".
2. Pursuant to the requirements of Regulation 9(1) of the Regulations, the Company has formulated a Code of Internal Procedures and Conduct to Regulate, Monitor and Report Trading by Insiders. |
|
|